ANI Pharmaceuticals reported $274.31M in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
AbbVie USD 62.48B 2.05B Jun/2026
ANI Pharmaceuticals USD 274.31M 5.84M Sep/2026
Aurora Cannabis CAD 16.81M 1.32M Jun/2026
Canopy Growth CAD 211.38M 5.74M Jun/2026
Eli Lilly USD 46.99B 872M Sep/2026
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Heron Therapeutics USD 140.64M 975K Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Nektar Therapeutics USD 60.27M 2.89M Mar/2026
Novartis USD 36.7B 748M Sep/2026
Omeros USD 403.72M 27.2M Jun/2024
Perrigo USD 3.28B 600K Sep/2026
Sun Pharmaceuticals INR 4.17B 237.8M Sep/2026
Teva Pharmaceutical Industries USD 12.68B 588M Sep/2026